Severe dyslipidemia in pregnancy: The role of therapeutic apheresis

Gianpaolo Russi

Research output: Contribution to journalReview article

Abstract

During pregnancy physiological changes occur in the lipid metabolism due to changing hormonal conditions: the LDL cholesterol (LDL-C), triglycerides (TG) and lipoprotein(a) [Lp(a)] increase throughout pregnancy. Common lipoprotein disorders are associated in pregnancy with two major clinical disorders: severe hypertriglyceridemia (SHTG) is a potent risk factor for development of acute pancreatitis and elevated cholesterol due to greater concentrations of LDL and remnant lipoproteins and reduced levels of HDL promote atherosclerosis. The combination of homozygous Familial Hypercholesterolemia (HoFH) and pregnancy can be a fatal condition. Therapeutic plasma exchange (TPE) may be used for an urgent need of a fast and effective lowering of TG levels in order to prevent a severe pancreatitis episode or hypertriglyceridemia-induced complications during pregnancy. LDL apheresis can decrease LDL-C and prevent complications and can be considered in the treatment of pregnancies complicated by high LDL-C. These conditions are configured in patients with HeFH who were taking statins before pregnancy (selected cases), patients already receiving apheresis before pregnancy suffering from HoFH, patients suffering from hypertriglyceridemia due to familial hyperlipoproteinemia types I and V, and cases of hypertriglyceridemia secondary to diabetes.

Original languageEnglish
Pages (from-to)283-287
Number of pages5
JournalTransfusion and Apheresis Science
Volume53
Issue number3
DOIs
Publication statusPublished - Dec 1 2015
Externally publishedYes

Fingerprint

Blood Component Removal
Dyslipidemias
Hypertriglyceridemia
Pregnancy
Hyperlipoproteinemia Type II
Pancreatitis
LDL Cholesterol
Therapeutics
Hyperlipoproteinemia Type V
Hyperlipoproteinemia Type I
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Plasma Exchange
Pregnancy Complications
Hypercholesterolemia
LDL Lipoproteins
Lipid Metabolism
Lipoproteins
Atherosclerosis
Triglycerides

Keywords

  • Acute pancreatitis
  • Homozygous Familial Hypercholesterolemia (HoFH)
  • LDL apheresis
  • Pregnancy
  • Severe hypertriglyceridemia (SHTG)
  • Therapeutic plasma exchange (TPE)

ASJC Scopus subject areas

  • Hematology

Cite this

Severe dyslipidemia in pregnancy : The role of therapeutic apheresis. / Russi, Gianpaolo.

In: Transfusion and Apheresis Science, Vol. 53, No. 3, 01.12.2015, p. 283-287.

Research output: Contribution to journalReview article

@article{58f16f98f8794507818bfe0c354ef153,
title = "Severe dyslipidemia in pregnancy: The role of therapeutic apheresis",
abstract = "During pregnancy physiological changes occur in the lipid metabolism due to changing hormonal conditions: the LDL cholesterol (LDL-C), triglycerides (TG) and lipoprotein(a) [Lp(a)] increase throughout pregnancy. Common lipoprotein disorders are associated in pregnancy with two major clinical disorders: severe hypertriglyceridemia (SHTG) is a potent risk factor for development of acute pancreatitis and elevated cholesterol due to greater concentrations of LDL and remnant lipoproteins and reduced levels of HDL promote atherosclerosis. The combination of homozygous Familial Hypercholesterolemia (HoFH) and pregnancy can be a fatal condition. Therapeutic plasma exchange (TPE) may be used for an urgent need of a fast and effective lowering of TG levels in order to prevent a severe pancreatitis episode or hypertriglyceridemia-induced complications during pregnancy. LDL apheresis can decrease LDL-C and prevent complications and can be considered in the treatment of pregnancies complicated by high LDL-C. These conditions are configured in patients with HeFH who were taking statins before pregnancy (selected cases), patients already receiving apheresis before pregnancy suffering from HoFH, patients suffering from hypertriglyceridemia due to familial hyperlipoproteinemia types I and V, and cases of hypertriglyceridemia secondary to diabetes.",
keywords = "Acute pancreatitis, Homozygous Familial Hypercholesterolemia (HoFH), LDL apheresis, Pregnancy, Severe hypertriglyceridemia (SHTG), Therapeutic plasma exchange (TPE)",
author = "Gianpaolo Russi",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.transci.2015.11.008",
language = "English",
volume = "53",
pages = "283--287",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Severe dyslipidemia in pregnancy

T2 - The role of therapeutic apheresis

AU - Russi, Gianpaolo

PY - 2015/12/1

Y1 - 2015/12/1

N2 - During pregnancy physiological changes occur in the lipid metabolism due to changing hormonal conditions: the LDL cholesterol (LDL-C), triglycerides (TG) and lipoprotein(a) [Lp(a)] increase throughout pregnancy. Common lipoprotein disorders are associated in pregnancy with two major clinical disorders: severe hypertriglyceridemia (SHTG) is a potent risk factor for development of acute pancreatitis and elevated cholesterol due to greater concentrations of LDL and remnant lipoproteins and reduced levels of HDL promote atherosclerosis. The combination of homozygous Familial Hypercholesterolemia (HoFH) and pregnancy can be a fatal condition. Therapeutic plasma exchange (TPE) may be used for an urgent need of a fast and effective lowering of TG levels in order to prevent a severe pancreatitis episode or hypertriglyceridemia-induced complications during pregnancy. LDL apheresis can decrease LDL-C and prevent complications and can be considered in the treatment of pregnancies complicated by high LDL-C. These conditions are configured in patients with HeFH who were taking statins before pregnancy (selected cases), patients already receiving apheresis before pregnancy suffering from HoFH, patients suffering from hypertriglyceridemia due to familial hyperlipoproteinemia types I and V, and cases of hypertriglyceridemia secondary to diabetes.

AB - During pregnancy physiological changes occur in the lipid metabolism due to changing hormonal conditions: the LDL cholesterol (LDL-C), triglycerides (TG) and lipoprotein(a) [Lp(a)] increase throughout pregnancy. Common lipoprotein disorders are associated in pregnancy with two major clinical disorders: severe hypertriglyceridemia (SHTG) is a potent risk factor for development of acute pancreatitis and elevated cholesterol due to greater concentrations of LDL and remnant lipoproteins and reduced levels of HDL promote atherosclerosis. The combination of homozygous Familial Hypercholesterolemia (HoFH) and pregnancy can be a fatal condition. Therapeutic plasma exchange (TPE) may be used for an urgent need of a fast and effective lowering of TG levels in order to prevent a severe pancreatitis episode or hypertriglyceridemia-induced complications during pregnancy. LDL apheresis can decrease LDL-C and prevent complications and can be considered in the treatment of pregnancies complicated by high LDL-C. These conditions are configured in patients with HeFH who were taking statins before pregnancy (selected cases), patients already receiving apheresis before pregnancy suffering from HoFH, patients suffering from hypertriglyceridemia due to familial hyperlipoproteinemia types I and V, and cases of hypertriglyceridemia secondary to diabetes.

KW - Acute pancreatitis

KW - Homozygous Familial Hypercholesterolemia (HoFH)

KW - LDL apheresis

KW - Pregnancy

KW - Severe hypertriglyceridemia (SHTG)

KW - Therapeutic plasma exchange (TPE)

UR - http://www.scopus.com/inward/record.url?scp=84983158569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983158569&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2015.11.008

DO - 10.1016/j.transci.2015.11.008

M3 - Review article

AN - SCOPUS:84983158569

VL - 53

SP - 283

EP - 287

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 3

ER -